AZ's Imfinzi on target in small cell lung cancer, sets up Roche rivalry - pharmaphorum

AZ's Imfinzi on target in small cell lung cancer, sets up Roche rivalry  pharmaphorum

AstraZeneca's Imfinzi cancer immunotherapy has hit the mark in phase 3 trial in extensive-stage small cell lung cancer.



Comments

Popular posts from this blog